Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 24.0847.24-21.1914.7853.68

What is the latest EBIT Growth ratio of TORRENT PHARMACEUTICALS ?

The latest EBIT Growth ratio of TORRENT PHARMACEUTICALS is 24.08 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202424.08
Mar202347.24
Mar2022-21.19
Mar202114.78
Mar202053.68

How is EBIT Growth of TORRENT PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 24.08
-49.03
Mar2023 47.24
Positive
Mar2022 -21.19
Negative
Mar2021 14.78
-72.47
Mar2020 53.68 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EBIT Growth ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹107,590.9 Cr 1.4% 1.3% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,519.0 Cr 1.6% -2.9% 17.2% Stock Analytics
DIVIS LABORATORIES ₹175,903.0 Cr 1.5% 10.4% 51.9% Stock Analytics
CIPLA ₹121,669.0 Cr 2.3% 1.9% 2.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,097.0 Cr 5.7% 14.1% 15.2% Stock Analytics
MANKIND PHARMA ₹97,239.7 Cr 0.2% -2.4% 12.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.4%

1.3%

17%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses